# Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability

> **NCT06047028** · — · RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Coronary Artery Disease
- Ischemic Heart Disease (IHD)
- Myocardial Viability

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06047028
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-30
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06047028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06047028, "Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06047028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*